Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
This article was originally published in The Pink Sheet
Executive Summary
FDA officials emphasize that without legislation from Congress, the OTC monograph program is not changing, and without a user fee program, the agency couldn’t implement changes.